Management of allosensitized cardiac transplant candidates (Q28749508)

Activation of coagulation and fibrinolytic pathways in patients with left ventricular assist devices

Europe PubMed Central

title

Management of allosensitized cardiac transplant candidates (English)

0 references

0 references

Mauricio Velez

1

0 references

Maryl R Johnson

series ordinal

2

0 references

language of work or name

English

0 references

publication date

October 2009

0 references

published in

Transplantation Reviews

0 references

volume

23

0 references

issue

4

0 references

page(s)

235-47

0 references

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2796825

Improved survival of patients with end-stage heart failure listed for heart transplantation: analysis of organ procurement and transplantation network/U.S. United Network of Organ Sharing data, 1990 to 2005.

16 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2796825

Registry of the International Society for Heart and Lung Transplantation: twenty-fourth official adult heart transplant report--2007.

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2796825

3 June 2018

Heart retransplantation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2796825

Acute antibody-mediated rejection following heart transplantation

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2796825

Understanding the sensitized patient

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2796825

Successful management of antibody-mediated cardiac allograft rejection with combined immunoadsorption and anti-CD20 monoclonal antibody treatment: case report and literature review

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2796825

Histocompatibility testing for highly sensitized transplant candidates

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2796825

Antibody and complement in transplant vasculopathy

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2796825

The emerging role of rituximab in organ transplantation

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2796825

Role of alloantibodies in the pathogenesis of graft arteriosclerosis in cardiac transplantation

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2796825

Acute antibody-mediated rejection of cardiac transplants

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2796825

Antibody-mediated rejection in human cardiac allografts: evaluation of immunoglobulins and complement activation products C4d and C3d as markers

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2796825

Humoral heart rejection (severe allograft dysfunction with no signs of cellular rejection or ischemia): incidence, management, and the value of C4d for diagnosis

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2796825

Sirolimus in de novo heart transplant recipients reduces acute rejection and prevents coronary artery disease at 2 years: a randomized clinical trial.

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2796825

Rituximab for reduction of anti-HLA antibodies in patients awaiting renal transplantation: 1. Safety, pharmacodynamics, and pharmacokinetics

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2796825

Rituximab (monoclonal anti-CD20 antibody): mechanisms of action and resistance

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2796825

Everolimus for the prevention of allograft rejection and vasculopathy in cardiac-transplant recipients

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2796825

Immunobiologic consequences of assist devices

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2796825

Allograft coronary artery disease: clinical correlations with circulating anti-HLA antibodies and the immunohistopathologic pattern of vascular rejection

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2796825

Factors influencing HLA sensitization in implantable LVAD recipients.

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2796825

Pretransplant panel reactive-antibody screens. Are they truly a marker for poor outcome after cardiac transplantation?

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2796825

Role of panel-reactive antibody cross-reactivity in predicting survival after orthotopic heart transplantation.

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2796825

Effect of IgM-positive crossmatches on survival in heart transplant recipients

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2796825

Humoral immune responses after cardiac transplantation: correlation with fatal rejection and graft atherosclerosis

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2796825

Long-term survival of kidney grafts

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2796825

Influence of panel-reactive antibody and lymphocytotoxic crossmatch on survival after heart transplantation

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2796825

Outcome of cardiac transplant recipients with a positive donor-specific crossmatch--preliminary results with plasmapheresis

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2796825

Prevalence and risks of allosensitization in HeartMate left ventricular assist device recipients: the impact of leukofiltered cellular blood product transfusions.

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2796825

Ventricular assist devices and aggressive immunosuppression: looking beyond overall survival.

27 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2796825

Impact of left ventricular assist device (LVAD)-mediated humoral sensitization on post-transplant outcomes.

27 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2796825

Lack of sensitization and equivalent post-transplant outcomes with the Novacor left ventricular assist device.

27 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2796825

C4d deposition in cardiac allografts correlates with alloantibody.

27 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2796825

Human leukocyte antigen sensitization in ventricular assist device recipients: a lesser risk with the DeBakey axial pump.

27 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2796825

Early and midterm risk of coronary allograft vasculopathy in patients bridged to orthotopic heart transplantation with ventricular assist devices.

27 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2796825

Early and late rejection and HLA sensitization at the time of heart transplantation in patients bridged with left ventricular assist devices

27 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2796825

Relationship between bridging with ventricular assist device on rejection after heart transplantation.

27 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2796825

In vivo human B-cell subset recovery after in vivo depletion with rituximab, anti-human CD20 monoclonal antibody.

27 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2796825

Outcome of patients surviving to heart transplantation after being mechanically bridged for more than 100 days

27 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2796825

Use of Rapamycin Slows Progression of Cardiac Transplantation Vasculopathy

27 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2796825

Humoral rejection in cardiac transplantation: risk factors, hemodynamic consequences and relationship to transplant coronary artery disease.

27 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2796825

HLA alloimmunization in patients requiring ventricular assist device support.

27 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2796825

Inflammatory response after implantation of a left ventricular assist device: comparison between the axial flow MicroMed DeBakey VAD and the pulsatile Novacor device.

27 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2796825

Plasmapheresis and cyclophosphamide in the treatment of humoral rejection after heart transplantation

27 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2796825

Platelet transfusions are associated with the development of anti-major histocompatibility complex class I antibodies in patients with left ventricular assist support.

27 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2796825

Use of intravenous immunoglobulin in sensitized LVAD recipients

27 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2796825

Presence of severe intimal thickening by intravascular ultrasonography predicts cardiac events in cardiac allograft vasculopathy

27 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2796825

Correlation of HLA matching with kidney graft survival in patients with or without cyclosporine treatment

27 November 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2009.07.001

Role of flow cytometry to define unacceptable HLA antigens in lung transplant recipients with HLA-specific antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2009.07.001

The effect of panel reactive antibodies and the donor specific crossmatch on graft survival after heart and heart-lung transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2009.07.001

Flow cytometric detection of HLA-specific antibodies as a predictor of heart allograft rejection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2009.07.001

Detection of anti-HLA antibody by flow cytometry in patients with a left ventricular assist device is associated with early rejection following heart transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2009.07.001

Immunologic sensitization in recipients of left ventricular assist devices

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2009.07.001

Development of anti-major histocompatibility complex class I or II antibodies following left ventricular assist device implantation: effects on subsequent allograft rejection and survival

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2009.07.001

Immunologic effects of implantation of left ventricular assist devices.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2009.07.001

Activation-induced T-cell death and immune dysfunction after implantation of left-ventricular assist device

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2009.07.001

B-cell activation and allosensitization after left ventricular assist device implantation is due to T-cell activation and CD40 ligand expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2009.07.001

Transitory immunologic response after implantation of the DeBakey VAD continuous-axial-flow pump

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2009.07.001

Plasmapheresis with intravenous immunoglobulin G is effective in patients with elevated panel reactive antibody prior to cardiac transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2009.07.001

Management of the sensitized cardiac recipient: the use of plasmapheresis and intravenous immunoglobulin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2009.07.001

Use of rituximab to decrease panel-reactive antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2009.07.001

Effect of plasmapheresis for acute humoral rejection after heart transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2009.07.001

Anti-CD20 monoclonal antibody (rituximab) therapy for acute cardiac humoral rejection: a case report

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2009.07.001

Refractory humoral cardiac allograft rejection successfully treated with a single dose of rituximab

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2009.07.001

Treatment of vascular rejection with rituximab in cardiac transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2009.07.001

Tissue plasminogen activator, plasminogen activator inhibitor-1, and fibrin as indexes of clinical course in cardiac allograft recipients. An immunocytochemical study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2009.07.001

Diagnostic and prognostic value of serial dobutamine stress echocardiography for noninvasive assessment of cardiac allograft vasculopathy: a comparison with coronary angiography and intravascular ultrasound

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2009.07.001

Monitoring of soluble HLA alloantigens and anti-HLA antibodies identifies heart allograft recipients at risk of transplant-associated coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2009.07.001

Posttransplantation cytotoxic immunoglobulin G is associated with a high rate of acute allograft dysfunctions in heart transplant recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2009.07.001

The presence of HLA-directed antibodies after heart transplantation is associated with poor allograft outcome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2009.07.001

Use of leukocyte-depleted platelet concentrates for the prevention of refractoriness and primary HLA alloimmunization: a prospective, randomized trial

7 January 2021

1 reference

12 December 2020

Multiparous women: is routine antibody screening enough in cardiac transplantation?

1 reference

12 December 2020

Vascular (humoral) rejection in human cardiac allograft biopsies: relation to circulating anti-HLA antibodies

1 reference

12 December 2020

Effect of anti-HLA antibodies on the long-term survival of heart and kidney allografts

1 reference

12 December 2020

Clinical-pathologic features of humoral rejection in cardiac allografts: a study in 81 consecutive patients

1 reference

12 December 2020

Covert presensitization to HLA antigens in parous heart and lung transplant recipients may predispose to early allograft rejection

1 reference

12 December 2020

Intravenous immunoglobulin reduces anti-HLA alloreactivity and shortens waiting time to cardiac transplantation in highly sensitized left ventricular assist device recipients

1 reference

12 December 2020

Plasmapheresis during cardiopulmonary bypass: a proposed treatment for presensitized cardiac transplantation patients

1 reference

12 December 2020

Donor-specific HLA antibodies after transplantation are associated with deterioration in cardiac function

1 reference

12 December 2020

10.1016/J.TRRE.2009.07.001

Identifiers

DOI

1 reference

1 reference

1 reference

PubMed publication ID

19778695

1 reference